bimzelx
ucb pharma s.a. - bimekizumab - psoriasi - immunosoppressori - plaque psoriasisbimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisbimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.
nimesulide ucb
ucb pharma s.p.a. - nimesulide - nimesulide
somatostatina ucb
ucb pharma s.a. - somatostatina - somatostatina
nootropil 800 mg compresse rivestite con film
ucb-pharma sa - piracetamum - compresse rivestite con film - piracetamum 800.00 mg, macrogolum 6000, silica colloidalis anhydrica, magnesii stearas, carmellosum natricum conexum corresp. natrium max 2.5 mg, pellicule: hypromellosum, e 171, macrogolum 400, macrogolum 6000, pro compresso obducto. - nootropikum - synthetika
nootropil 1200 mg compresse rivestite con film
ucb-pharma sa - piracetamum - compresse rivestite con film - piracetamum 1200.00 mg, macrogolum 6000, silica colloidalis anhydrica, magnesii stearas, carmellosum natricum conexum corresp. natrium max. 3.75 mg, pellicule: hypromellosum, e 171, macrogolum 400, macrogolum 6000, pro compresso obducto. - nootropikum - synthetika
atarax compresse rivestite con film
ucb-pharma sa - hydroxyzini hydrochloridum - compresse rivestite con film - hydroxyzini hydrochloridum 25 mg, lactosum monohydricum 54.8 mg, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, pellicule: hypromellosum, macrogolum 400, e 171 pro compresso obducto. - sedativi, antistaminici - synthetika
atarax sirup
ucb-pharma sa - hydroxyzini hydrochloridum - sirup - hydroxyzini hydrochloridum 25 mg, ethanolum 96 per centum 12.5 mg, saccharum 9.375 g, aqua purificata, levomentholum, aromatica, e 211 3.75 mg corresp. natrium 0.598 mg ad solutionem pro 12.5 ml. - sedativum, antihistaminikum - synthetika
ferro sanol gélules à libération modifiée
ucb-pharma sa - ferro da stiro - gélules à libération modifiée - ferrum 100 mg ut ferrosi glycinatis sulfas ut ferrosi sulfas heptahydricus et glycinum, e 300, cellulosum microcristallinum, hypromellosum, hydroxypropylcellulosum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas, polysorbatum 80, triethylis acetylcitras, talcum, matériel de la capsule: gelatina, e 171, e 172 (rubrum), e 172 (nigrum), e 172 (flavum), pro capsula corresp. natrium 0.0239 mg. - anemia da carenza di ferro si è rivelato essere - synthetika
nootropil solution buvable 333.3 mg/ml
ucb-pharma sa - piracetamum - solution buvable 333.3 mg/ml - piracetamum 333.3 mg, glycerolum (85 per centum) 270.0 mg, e 218 1.8 mg, propylis parahydroxybenzoas 0.2 mg, natrii acetas trihydricus corresp. natrium 0.3377 mg, acidum aceticum glaciale, aqua purificata q.s. ad solutionem pro 1 ml. - nootropikum - synthetika
keppra 250 mg compresse rivestite con film
ucb-pharma sa - levetiracetamum - compresse rivestite con film - levetiracetamum 250 mg, carmellosum natricum solo tenuti insieme, macrogolum 6000, silice colloidalis anhydrica, magnesio stearas, poli(alcole vinylicus), macrogolum 3350, talco, e 132, e 171 per compresso haze corrisp. sodio 0,7 mg. - aed - synthetika